One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

Altamira Therapeutics Ltd. (OTCQB:CYTOF) today announced that the U.S. Patent and Trademark Office ("USPTO") has issued a Notice of Allowance for a patent (application #17/466,142) relating to the ...

This important study investigates the role of ATG6 in regulating NPR1, a key protein in the plant immune response. The authors present compelling evidence that ATG6 not only interacts with NPR1 in ...

Al­ny­lam may be gear­ing up for its biggest com­mer­cial launch yet in its near­ly 23-year his­to­ry, but the com­pa­ny’s top sci­en­tists be­lieve they are just … ...

siRNA能抑制特定致癌基因表达，展现出较好的抗肿瘤潜力。然而其临床应用面临多重障碍，如负电荷亲水性阻碍细胞摄取，溶酶体逃逸能力不足导致 ...

Spray-Induced Gene Silencing (SIGS) technology uses foliar dsRNA sprays to protect ... addressing these questions will be crucial for optimizing the efficacy and safety of SIGS in sustainable ...

Intranasal vaccination is a desired route for protection against influenza viruses by mucosal and systemic immunity. However, the nasal mucosa impedes the intranasal delivery of vaccines. Here, we ...

Then, it develops siRNA therapeutics against these targets ... CEO – Created the technology for Impel Pharmaceuticals’ Trudhesa® nasal spray during his Ph.D. and led it to FDA approval ...

Center for Infections and Genomics of the Lung (CIGL) Justus Liebig University Giessen German Center for Lung Research, Aulweg 132, 35392 Gießen, Germany Center for Infections and Genomics of the Lung ...